Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Stock Options Activity

A summary of the status of the Company’s stock options as of December 31, 2018, 2019 and 2020 and changes during the years then ended, is presented below:

 

    2018     2019     2020  
    Number of Shares     Weighted- Average Exercise Price     Number of
Shares
    Weighted- Average
Exercise
Price
    Number
of Shares
    Weighted-
Average
Exercise
Price
 
                                     
Outstanding at beginning of year     1,290     $ 5.33       1,220     $ 5.37       4,078     $ 5.79  
Share-based payments assumed     -               127       4.35       -          
Granted     120       6.41       2,829       5.99       1,230       6.08  
Exercised     (169 )     5.73       (59 )     3.79       (199 )     4.72  
Forfeited or expired     (21 )     5.96       (39 )     6.22       (1,485 )     6.02  
                                                 
Outstanding at end of year     1,220     $ 5.37       4,078     $ 5.79       3,624     $ 5.85  
                                                 
Exercisable at end of year     695     $ 5.07       847     $ 5.71       1,247     $ 5.60  

Summary of Stock Option Information by Exercise Price Range

The following table summarizes information about stock options at December 31, 2020.

 

    Options Outstanding     Options Exercisable  
Exercise Prices ($)  

Number

Outstanding

   

Weighted- Average Remaining

Contractual Life in Years

   

Weighted-

Average

Exercise Price

   

Number

Outstanding

   

Weighted-

Average

Exercise Price

 
                               
2.33 - 3.63     16       3     $ 2.33       16     $ 2.33  
3.64 - 4.93     276       6       4.64       168       4.63  
4.94 - 6.23     2,767       8       5.89       1,063       5.81  
6.24 - 7.54     565       9       6.33       -       0.00  
                                         
      3,624       8     $ 5.85       1,247     $ 5.60  
Schedule of Options Outstanding and Exercisable
    As of December 31, 2020  
   

Aggregate

Intrinsic Value

   

Weighted -

Average

Remaining

Contractual Life

in Years

 
             
Options outstanding   $ 6,055       8  
Options exercisable   $ 2,392       7  
Schedule of Fair Value Stock Option Assumptions

The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model reflecting the following weighted-average assumptions:

 

    Year Ended December 31,  
    2018     2019     2020  
                   
Expected volatility     42.8 %     42.1 %     47.1 %
Expected life of options     4.4 years       6.7 years       6.3 years  
Risk free interest rate     2.72 %     1.64 %     0.93 %
Dividend yield     0 %     0 %     0 %
Weighted-average fair value of options granted during year   $ 2.46     $ 2.20     $ 2.69  
Schedule of Non-vested Restricted Stock Activity

A summary of the non-vested shares for the years ended December 31, 2018, 2019 and 2020 is as follows:

 

   

Number of

Non-Vested

Shares

   

Weighted -

Average

Grant Date

Fair Value

 
             
Non-vested, at January 1, 2018     430       5.91  
Granted     434       7.02  
Vested     (266 )     6.07  
Forfeited     (30 )     6.54  
                 
Non-vested, at December 31, 2018     568       6.65  
Granted     625       5.82  
Vested     (276 )     6.40  
Forfeited     (40 )     5.88  
                 
Non-vested, at December 31, 2019     877       6.17  
Granted     463       4.88  
Vested     (389 )     6.01  
Forfeited     (145 )     6.01  
                 
Non-vested, at December 31, 2020     806       5.54  
Restricted Stock Units (RSUs) [Member]  
Schedule of Non-vested Restricted Stock Activity

The Company also grants restricted stock units (RSUs) to employees. The following table summarizes the activity relating to the Company’s restricted stock units for the years ended December 31, 2019 and 2020:

 

   

Number of

Restricted

Stock Units

   

Weighted -

Average

Grant Date

Fair Value

 
             
Pointer share-based payments assumed     260     $ 5.60  
Vested     (7 )     5.60  
Forfeited     -          
Restricted stock-units, non-vested December 31, 2019     253     $ 5.60  
Vested     (148 )     5.60  
Forfeited     (30 )     5.60  
                 
Restricted stock-units, non-vested, December 31, 2020     75     $ 5.60  
Performance Shares [Member]  
Schedule of Non-vested Restricted Stock Activity

The following table summarizes the activity relating to the Company’s performance shares for the years ended December 31, 2018, 2019 and 2020:

 

    Number of Non-Vested Shares     Weighted - Average Grant Date Fair Value  
             
Performance shares, non-vested, at January 1, 2018     111       4.07  
Granted     -       -  
Vested     (93 )     4.07  
Forfeited     (18 )     4.07  
Performance shares, non-vested, at December 31, 2018     -       -  
Granted     -       -  
Vested     -       -  
Forfeited     -       -  
Performance shares, non-vested, at December 31, 2019     -       -  
Granted     -       -  
Vested     -       -  
Forfeited     -       -  
Performance shares, non-vested, at December 31, 2020     -       -